RecruitingPhase 2NCT06273072

Metformin IN Asthma for Overweight and Obese Individuals (MINA)


Sponsor

Johns Hopkins University

Enrollment

100 participants

Start Date

Dec 9, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This is a randomized clinical trial of metformin among overweight or obese adults with not well-controlled asthma despite maintenance inhaler therapy.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether metformin — a common diabetes medication — can improve asthma control in overweight and obese adults whose asthma is not well-controlled despite current treatment. Researchers believe metformin may reduce airway inflammation. **You may be eligible if...** - You are 18 or older - You have a doctor-diagnosed asthma on regular maintenance treatment - Your asthma is not well controlled (you score below 20 on the Asthma Control Test or had at least one flare requiring steroids in the past year) - Your BMI is 25 kg/m² or higher (overweight or obese) **You may NOT be eligible if...** - You are pregnant or planning to become pregnant - You have had a heart attack, stroke, or heart failure in the past 6 months - You have other chronic lung diseases such as COPD or pulmonary fibrosis - You are a current smoker or have a significant smoking history Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMetformin hydrochloride extended-release tablets

titrated to 2000 mg once daily

DRUGVisually identical placebo Metformin hydrochloride extended-release tablets

placebo


Locations(2)

Johns Hopkins University

Baltimore, Maryland, United States

Baylor College of Medicine

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06273072


Related Trials